109 related articles for article (PubMed ID: 8364771)
1. Clinical documentation of inflammation markers in asthma.
Midander J
Clin Exp Allergy; 1993 Jun; 23 Suppl 2():13-4, discussion 15-22. PubMed ID: 8364771
[No Abstract] [Full Text] [Related]
2. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity.
Ferdousi HA; Dreborg S
Clin Exp Allergy; 1997 May; 27(5):530-9. PubMed ID: 9179427
[TBL] [Abstract][Full Text] [Related]
3. Serum eosinophil cationic protein measurements in monitoring pulmonary inflammation in asthma.
Brand PL
Arch Dis Child; 1996 Jul; 75(1):88. PubMed ID: 8813881
[No Abstract] [Full Text] [Related]
4. Mild exacerbations and eosinophilic inflammation in patients with stable, well-controlled asthma after 1 year of follow-up.
Belda J; Giner J; Casan P; Sanchis J
Chest; 2001 Apr; 119(4):1011-7. PubMed ID: 11296162
[TBL] [Abstract][Full Text] [Related]
5. [Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow].
Nakazawa T; Kagami M; Matumura R; Kawashima T; Matuzuwa Y; Takada M
Arerugi; 1999 Oct; 48(10):1153-60. PubMed ID: 10554401
[TBL] [Abstract][Full Text] [Related]
6. Effect of a bed covering system in children with asthma and house dust mite hypersensitivity.
Frederick JM; Warner JO; Jessop WJ; Enander I; Warner JA
Eur Respir J; 1997 Feb; 10(2):361-6. PubMed ID: 9042633
[TBL] [Abstract][Full Text] [Related]
7. Relationship between induced sputum cell counts and fluid-phase eosinophil cationic protein and clinical or physiologic profiles in mild asthma.
Gutiérrez V; Prieto L; Torres V; Trenor R; Pérez C; Bertó JM; Marín J
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):559-65. PubMed ID: 10400484
[TBL] [Abstract][Full Text] [Related]
8. Eosinophil markers in childhood asthma.
O'Sullivan S; Kumlin M
Clin Exp Allergy; 1999 Nov; 29(11):1454-6. PubMed ID: 10520071
[No Abstract] [Full Text] [Related]
9. Serum eosinophil cationic protein (sECP) in subjects with a history of asthma symptoms with or without rhinitis.
Perfetti L; Galdi E; Bramé B; Speciale L; Moscato G
Allergy; 1999 Sep; 54(9):962-7. PubMed ID: 10505459
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma.
Ferguson AC; Vaughan R; Brown H; Curtis C
J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):23-8. PubMed ID: 7822660
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma.
Sahid El-Radhi A; Hogg CL; Bungre JK; Bush A; Corrigan CJ
Arch Dis Child; 2000 Aug; 83(2):158-62. PubMed ID: 10906027
[TBL] [Abstract][Full Text] [Related]
12. Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication.
Venge P; Dahl R; Peterson CG
Int Arch Allergy Appl Immunol; 1988; 87(3):306-12. PubMed ID: 3144513
[TBL] [Abstract][Full Text] [Related]
13. Serum eosinophilic cationic protein as a marker of disease activity in chronic asthma.
Chanarin N; Skinner SP; Church MK
J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):705-6. PubMed ID: 7499697
[No Abstract] [Full Text] [Related]
14. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia.
Griffin E; Håkansson L; Formgren H; Jörgensen K; Peterson C; Venge P
J Allergy Clin Immunol; 1991 Feb; 87(2):548-57. PubMed ID: 1847158
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma.
Frigas E; Loegering DA; Solley GO; Farrow GM; Gleich GJ
Mayo Clin Proc; 1981 Jun; 56(6):345-53. PubMed ID: 7230899
[TBL] [Abstract][Full Text] [Related]
16. Eosinophils and eosinophil-derived proteins in children with moderate asthma.
Hoekstra MO; Hovenga H; Gerritsen J; Kauffman HF
Eur Respir J; 1996 Nov; 9(11):2231-5. PubMed ID: 8947065
[TBL] [Abstract][Full Text] [Related]
17. Pranlukast, a cysteinyl leukotriene antagonist, reduces serum eosinophil cationic protein levels in patients with asthma.
Ishioka S; Hozawa S; Haruta Y; Hiyama K; Maeda A; Yamakido M
Hiroshima J Med Sci; 1999 Dec; 48(4):105-10. PubMed ID: 10804983
[TBL] [Abstract][Full Text] [Related]
18. Can early asthma be confirmed by laboratory tests?
Metso T; Kilpiö K; Björkstén F; Kiviranta K; Haahtela T
Allergy; 1996 Apr; 51(4):226-31. PubMed ID: 8792918
[TBL] [Abstract][Full Text] [Related]
19. Hypodense eosinophil number relates to clinical severity, airway hyperresponsiveness and response to inhaled corticosteroids in asthmatic subjects.
Kuo HP; Yu TR; Yu CT
Eur Respir J; 1994 Aug; 7(8):1452-9. PubMed ID: 7957830
[TBL] [Abstract][Full Text] [Related]
20. [Peak expiratory flow rate (PEF) and serum eosinophil cationic protein (ECP) changes in nocturnal asthmatics].
Sun B; Wang H; Liu X
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Jun; 18(3):143-5, 189. PubMed ID: 8565079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
